No longer thinking my "$50b" napkin is just an ill

No longer thinking my "$50b" napkin is just an illustrative comparison of Cytodyn potential:

May 2nd:
https://stocktwits.com/my69z/message/613335688

Roza Ogurlu:
https://stocktwits.com/my69z/message/613116294

April 27th:
https://stocktwits.com/my69z/message/612808505

Non-ESMO trials:
https://stocktwits.com/my69z/message/612700907

Leronlimab significant advantages over all drugs:
https://stocktwits.com/my69z/message/612699213

1 quick Trodelvy comparison:
https://stocktwits.com/my69z/message/611814082
Leronlimab/ Aspirin/ Penicillin:
https://stocktwits.com/my69z/message/610511912

Aspirin & Leronlimab:
https://stocktwits.com/my69z/message/610527347

Penicillin & Leronlimab:
https://investorshangout.com/post/view?id=6753844

90% of all cancers, are solid tumors.

On manufacturing:
1 consortium that produces all LL products for indications @ cost + 10%. The facility alone will be a profit machine after a few years.

Above reasons & from Feb. 2025 mTNBC news, to a new CFO, "ESMO events" & stunning 52 months cancer-free....are some of why i think my hypothetical "$50b" napkin used for illustrating Cytodyn's possible potential..( & beyond )....is no longer just a hypothetical for passing time while waiting for news.

Leronlimab & Long Acting Leronlimab will =
New Standard of Care.

https://stocktwits.com/my69z/message/605379821